Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?
<p>Abstract</p> <p>Background</p> <p>Nesiritide is indicated in the treatment of acute decompensated heart failure. However, a recent meta-analysis reported that nesiritide may be associated with an increased risk of death. Our goal was to evaluate the impact of nesirit...
Main Authors: | Hauck Loran D, Mulla Zuber D, Carroll Richard J, Westbrook Audrey |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-11-01
|
Series: | BMC Cardiovascular Disorders |
Online Access: | http://www.biomedcentral.com/1471-2261/7/37 |
Similar Items
-
A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritide
by: Starr JA, et al.
Published: (2009-09-01) -
Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis
by: Xuecheng Zhao, et al.
Published: (2020-01-01) -
The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials.
by: Bo Xiong, et al.
Published: (2015-01-01) -
Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)
by: Ankeet S. Bhatt, et al.
Published: (2018-02-01) -
Risk stratification for in-hospital mortality in acutely decompensated heart failure.
by: Royston, P, et al.
Published: (2005)